Cilostazol Stroke Prevention Study for Antiplatelet Combination "CSPS・com"


Phase 3 Results N/A

Summary of Purpose

To examine the efficacy and safety of dual antiplatelet therapy (DAPT) including cilostazol (Pletaal OD Tablet ®) in comparison with antiplatelet monotherapy (excluding cilostazol) for secondary prevention of ischemic stroke in high-risk patients for stroke

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 3 December 2013.

1 Oct 2013 15 Nov 2013 1 Mar 2017 1 Mar 2017 1 Dec 2013 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Prevention
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment